Comparing Capecitabine Plus Oxaliplatin Versus Capecitabine Plus Oxaliplatin With Concurrent Capecitabine Radiation Therapy in Completely Resected Gastric Cancer

被引：0
|
作者：
Zhang, L. Y. [1 ]
Wu, Y. Y. [2 ]
Qian, J. J. [1 ]
Chen, L. S. [1 ]
Tian, Y. [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 2, Dept Gen Surg, Suzhou, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.828
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S316 / S316
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant Capecitabine and Oxaliplatin Before Concurrent Capecitabine and Radiation in Locally Advanced Rectal Cancers: Experience of a Cancer Hospital in Pakistan
    Mansha, Muhammad Atif
    Waheed, Asmara
    Sadaf, Tabinda
    Rashid, Asma
    Irfan, Nabia
    Chaudry, Samreen Javed
    JCO GLOBAL ONCOLOGY, 2021, 7 : 790 - 796
  • [42] Phase III study of 5-fluorouracil/leucovorin plus oxaliplatin versus capecitabine plus oxaliplatin as first line therapy in patients with advanced colorectal cancer (ACRC)
    Porschen, R
    Arkenau, T
    Kubicka, S
    Schmoll, HJ
    Seufferlein, T
    Graeven, U
    Grothey, A
    GASTROENTEROLOGY, 2005, 128 (04) : A438 - A438
  • [43] Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers
    Chen, Ruijia
    Zhang, Yalan
    Lin, Kongying
    Huang, Defu
    You, MaoJin
    Lai, Yanjin
    Wang, Jinye
    Hu, Yingying
    Li, Na
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [44] Capecitabine and oxaliplatin for advanced esophagogastric cancer
    Cunningham, David
    Starling, Naureen
    Rao, Sheela
    Iveson, Timothy
    Nicolson, Marianne
    Coxon, Fareeda
    Middleton, Gary
    Daniel, Francis
    Oates, Jacqueline
    Norman, Andrew Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (01): : 36 - 46
  • [45] ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED COLON-RECTUM CANCER IN CHINA
    Chen, W.
    VALUE IN HEALTH, 2010, 13 (07) : A263 - A263
  • [46] Capecitabine plus weekly oxaliplatin in gastrointestinal tumors - A phase I study
    Carlomagno, C
    Orditura, M
    Pepe, S
    De Vita, F
    Romano, C
    Ciardiello, F
    Ferrara, C
    Martinelli, E
    Bianco, R
    Aurilio, G
    D'Agostino, D
    Tortora, G
    Catalano, G
    De Placido, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (01): : 85 - 89
  • [47] Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients
    Natsumi Matsumoto
    Yutaro Kubota
    Hiroo Ishida
    Masae Sekido
    Ryotaro Ohkuma
    Tomoyuki Ishiguro
    Yuya Hirasawa
    Hirotsugu Ariizumi
    Takuya Tsunoda
    Toshikazu Ikusue
    Kouji Kobayashi
    Atsushi Hisamatsu
    Hirokazu Toshima
    Ken Shimada
    Ken-ichi Fujita
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 1119 - 1128
  • [48] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Hasegawa, J.
    Kato, T.
    Nishimura, J.
    Yoshioka, S.
    Noura, S.
    Kagawa, Y.
    Yasui, M.
    Ikenaga, M.
    Murata, K.
    Hata, T.
    Matsuda, C.
    Mizushima, T.
    Yamamoto, H.
    Doki, Y.
    Mori, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [49] Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer
    Arnold, D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (02) : 196 - 197
  • [50] Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer
    Luigi Di Lauro
    Patrizia Vici
    Franca Belli
    Silverio Tomao
    Silvia Ileana Fattoruso
    Maria Grazia Arena
    Laura Pizzuti
    Diana Giannarelli
    Giancarlo Paoletti
    Maddalena Barba
    Domenico Sergi
    Marcello Maugeri-Saccà
    Gastric Cancer, 2014, 17 : 718 - 724
12345